BANK OF AMERICA CORP /DE/ - TEVA PHARMACEUTICAL FIN LLC ownership

TEVA PHARMACEUTICAL FIN LLC's ticker is and the CUSIP is 88163VAE9. A total of 47 filers reported holding TEVA PHARMACEUTICAL FIN LLC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.8%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of TEVA PHARMACEUTICAL FIN LLC
ValueSharesWeighting
Q3 2022$2,000
-33.3%
3,0000.0%0.00%
Q2 2022$3,0000.0%3,0000.0%0.00%
Q1 2022$3,0000.0%3,0000.0%0.00%
Q4 2021$3,0000.0%3,0000.0%0.00%
Q3 2021$3,0000.0%3,0000.0%0.00%
Q2 2021$3,0000.0%3,0000.0%0.00%
Q1 2021$3,0000.0%3,0000.0%0.00%
Q4 2020$3,000
-76.9%
3,000
-76.9%
0.00%
Q3 2020$13,0000.0%13,0000.0%0.00%
Q2 2020$13,000
+333.3%
13,000
+333.3%
0.00%
Q1 2020$3,0000.0%3,0000.0%0.00%
Q4 2019$3,0000.0%3,0000.0%0.00%
Q3 2019$3,000
-98.1%
3,000
-98.2%
0.00%
Q2 2019$154,000
+5033.3%
168,000
+5500.0%
0.00%
Q1 2019$3,0000.0%3,0000.0%0.00%
Q4 2018$3,000
-25.0%
3,000
-25.0%
0.00%
Q3 2018$4,0000.0%4,0000.0%0.00%
Q2 2018$4,000
-87.9%
4,000
-89.5%
0.00%
Q1 2018$33,000
+725.0%
38,000
+850.0%
0.00%
Q4 2017$4,000
-99.8%
4,000
-99.8%
0.00%
Q3 2017$1,985,000
-43.1%
2,202,000
-32.3%
0.00%
-100.0%
Q2 2017$3,488,000
+1.1%
3,252,000
+1.2%
0.00%0.0%
Q1 2017$3,450,000
-18.6%
3,213,000
-17.0%
0.00%0.0%
Q4 2016$4,239,000
-2.9%
3,871,000
+5.9%
0.00%0.0%
Q3 2016$4,364,000
+18.2%
3,657,000
+25.3%
0.00%0.0%
Q2 2016$3,691,000
+54.8%
2,918,000
+59.2%
0.00%0.0%
Q1 2016$2,385,000
-54.5%
1,832,500
-45.5%
0.00%0.0%
Q4 2015$5,247,000
-15.7%
3,360,500
-27.0%
0.00%
-50.0%
Q3 2015$6,225,000
+28195.5%
4,604,500
+28678.1%
0.00%
Q2 2015$22,000
+120.0%
16,000
+128.6%
0.00%
Q1 2015$10,000
+11.1%
7,0000.0%0.00%
Q4 2014$9,0000.0%7,0000.0%0.00%
Q3 2014$9,000
-82.4%
7,000
-82.5%
0.00%
Q2 2014$51,000
+466.7%
40,000
+471.4%
0.00%
Q1 2014$9,000
+80.0%
7,000
+40.0%
0.00%
Q4 2013$5,000
-77.3%
5,000
-76.2%
0.00%
Q3 2013$22,000
+2100.0%
21,000
+2000.0%
0.00%
Q2 2013$1,0001,0000.00%
Other shareholders
TEVA PHARMACEUTICAL FIN LLC shareholders Q4 2020
NameSharesValueWeighting ↓
Radcliffe Capital Management, L.P. 70,783,000$69,363,0006.27%
INCOME RESEARCH & MANAGEMENT 14,978,000$14,536,0005.17%
PIPER SANDLER & CO. 5,000,000$4,852,0003.63%
Western Asset Management Company, LLC 42,946,000$42,102,0003.46%
PenderFund Capital Management Ltd. 4,000,000$5,225,0001.45%
Bracebridge Capital, LLC 5,500,000$5,335,0000.85%
WESTWOOD HOLDINGS GROUP INC 43,185,000$42,490,0000.54%
CORBYN INVESTMENT MANAGEMENT INC/MD 1,025,000$995,0000.52%
LMR Partners LLP 22,235,000$21,742,0000.45%
JUPITER ASSET MANAGEMENT LTD 35,000,000$34,357,0000.36%
View complete list of TEVA PHARMACEUTICAL FIN LLC shareholders